Hans‐Peter Gerber
Hans‐Peter Gerber publishes mostly in Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Angiogenesis and VEGF in Cancer.
- World rank
- #22,491 of 7,710,434 ranked researchers
- Rank in United States
- #8,273 of 1,627,098
- Works
- 240
- Citations
- 28k
- Citations per work
- 117.8
What does Hans‐Peter Gerber research?
Hans‐Peter Gerber's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10644.0%
- Medicine10644.0%
- Life Sciences7330.6%
- Everything else6125.4%
- 1Oncology25% of their works
- 2Molecular Biology18% of their works
- 3Radiology, Nuclear Medicine and Imaging16% of their works
- 4Immunology6% of their works
- 5Cancer Research6% of their works
- 6Immunology and Allergy4% of their works
Research topics
Which keywords describe Hans‐Peter Gerber's research?
The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Breast Cancer, HER2, endothelial progenitor cells, VEGF, CAR T Cells and Chimeric Antigen Receptor.
- Tumor Metastasis
- PET Imaging
- Integrins
- Warburg Effect
- Chimeric Antigen Receptor
- endothelial progenitor cells
- HER2
- Therapeutic Antibodies
- Fc Receptors
- Breast Cancer
- VEGF
- CAR T Cells
- HIF-1
- Cell Adhesion
- Cancer Stem Cells
- Radiopharmaceuticals
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Fc Receptors521 topic
- Therapeutic Antibodies521 topic
- Breast Cancer431 topic
- HER2431 topic
- VEGF401 topic
- endothelial progenitor cells401 topic
- CAR T Cells181 topic
- Chimeric Antigen Receptor181 topic
- HIF-1181 topic
- Warburg Effect181 topic
- Cell Adhesion111 topic
- Integrins111 topic
- Cancer Stem Cells101 topic
- PET Imaging101 topic
- Radiopharmaceuticals101 topic
- Tumor Metastasis101 topic
Where does Hans‐Peter Gerber work?
Hans‐Peter Gerber's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Hans‐Peter Gerber have?
OpenAlex counts 240 works and 28,269 citations for Hans‐Peter Gerber, an h-index of 58, ranking #22,491 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Hans‐Peter Gerber
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hans‐Peter Gerber. Posts are plain text and can be reported.